Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Sanofi (SNYNF) SEC Filings & 10K Form

Sanofi logo
$100.26 +0.23 (+0.23%)
As of 03:59 PM Eastern
Compare

Recent Sanofi SEC Filings

Export to Excel
DateFilerForm TypeView
07/31/2025
10:33 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/31/2025
7:06 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/31/2025
6:34 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/30/2025
7:09 AM		Sanofi (Filer)
Sanofi (Filer)
Form N-PX
Annual Report of Proxy Voting Record of Registered Management Investment Company  
07/29/2025
11:18 AM		Sanofi (Filer)
Sanofi (Filer)
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
07/22/2025
7:49 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/18/2025
5:03 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/17/2025
5:04 AM		Blueprint Medicines Corp (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
Form SC TO-T/A
07/10/2025
5:04 AM		Blueprint Medicines Corp (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
Form SC TO-T/A
07/02/2025
7:25 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/27/2025
3:49 PM		Sanofi (Filer)
Sanofi (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/24/2025
7:31 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/18/2025
5:43 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/17/2025
7:33 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/17/2025
5:07 AM		Blueprint Medicines Corp (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
Form SC TO-T
06/06/2025
10:35 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/02/2025
4:11 PM		Blueprint Medicines Corp (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
Form SC TO-C
06/02/2025
5:09 AM		Blueprint Medicines Corp (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
Form SC TO-C
06/02/2025
5:07 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/30/2025
9:51 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/22/2025
7:09 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/21/2025
9:55 AM		Sanofi (Filer)
Sanofi (Filer)
Form SD
Specialized Disclosure Report  
05/12/2025
3:50 PM		Amundi (Filed by)
Sanofi (Subject)
Sanofi (Subject)
Form SCHEDULE 13G/A
05/06/2025
5:15 AM		Sanofi (Filer)
Sanofi (Filer)
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
05/05/2025
12:12 PM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/30/2025
1:50 PM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2025
5:48 PM		Innate Pharma SA (Subject)
Innate Pharma SA (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
Form SCHEDULE 13G/A
04/24/2025
9:13 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/23/2025
6:39 PM		BlackRock, Inc. (Filed by)
Sanofi (Subject)
Sanofi (Subject)
Form SCHEDULE 13G/A
04/22/2025
11:29 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/16/2025
8:18 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/10/2025
5:11 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/04/2025
7:43 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/02/2025
5:15 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/27/2025
12:39 PM		Sanofi (Filer)
Sanofi (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/26/2025
10:56 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/21/2025
5:04 AM		Sanofi (Filer)
Sanofi (Filer)
Form S-8 POS
03/20/2025
10:06 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/10/2025
11:23 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/06/2025
9:24 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/28/2025
5:14 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
When the levee breaks (Ad)

The U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was projected. According to Porter Stansberry, this is panic-level borrowing… and a clear sign we’re nearing America’s financial breaking point. In his latest emergency briefing, Porter outlines why the cracks in our system are widening fast—and how Trump’s policies may be accelerating the collapse. More importantly, he reveals three moves you can make now to protect and potentially grow your wealth before the levee breaks.tc pixel

Click here to watch the urgent broadcast and get ahead of what’s coming.
02/20/2025
11:18 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2025
11:14 AM		Amundi (Filed by)
Sanofi (Subject)
Sanofi (Subject)
Form SCHEDULE 13G/A
02/14/2025
10:28 AM		Sanofi (Filer)
Sanofi (Filer)
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
02/13/2025
1:11 PM		Sanofi (Filer)
Sanofi (Filer)
Form IRANNOTICE
02/13/2025
12:41 PM		Sanofi (Filer)
Sanofi (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
02/13/2025
11:23 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/07/2025
10:14 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/03/2025
11:14 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/30/2025
8:50 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/24/2025
5:04 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/14/2025
7:40 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/23/2024
1:08 PM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/20/2024
5:07 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/13/2024
10:07 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/18/2024
11:23 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/07/2024
1:49 PM		Amundi (Filed by)
Sanofi (Subject)
Sanofi (Subject)
Form SC 13G/A
11/07/2024
10:35 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/31/2024
5:56 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/25/2024
11:39 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/21/2024
10:47 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/11/2024
2:35 PM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/02/2024
10:06 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/24/2024
1:51 PM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/13/2024
11:46 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/03/2024
9:46 AM		Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (OTCMKTS:SNYNF) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsoredtc pixel
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Paradigm Press | Sponsoredtc pixel
Tax Drain Deadline: Protect Your Wealth Before September 15th
On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...
American Alternative | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel
Think you missed gold’s boom? Think again
If you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...
Investors Alley | Sponsoredtc pixel
Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...
Brownstone Research | Sponsoredtc pixel
A grave, grave error.
Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...
Porter & Company | Sponsoredtc pixel
Out of 18,347 Cryptocurrencies... This is the ONLY One
The $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...
Crypto 101 Media | Sponsoredtc pixel